The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1054
ISSUE1054
June 4, 1999
Interferon Plus Ribavirin for Chronic Hepatitis C
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Interferon Plus Ribavirin for Chronic Hepatitis C
June 4, 1999 (Issue: 1054)
Rebetron, a combination of injected recombinant interferon alfa-2b with oral ribavirin has been approved by the FDA for treatment of chronic hepatitis C virus infection.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.